Skip to content

Mindfulness for People With Incurable Cancer

A Pilot Investigation of a Mindfulness Course for People With Incurable Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03446092
Enrollment
3
Registered
2018-02-26
Start date
2018-11-19
Completion date
2020-05-30
Last updated
2022-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer, Mindfulness, Palliative care

Brief summary

The study will investigate whether a mindfulness course can help people with incurable cancer who are seen by oncologists in a particular National Health Service Hospital Trust in the United Kingdom.

Detailed description

It can be hard to come to terms with living with a life limiting condition such as incurable cancer and individuals are at risk of experiencing high levels of psychological distress, which can often be overlooked when the focus is on managing physical symptoms. Mindfulness-based interventions have been shown to be helpful in reducing distress for people with cancer generally. This pilot study will use an established mindfulness programme called mindfulness for health with people with cancer which is incurable to see if this type of intervention is acceptable and useful for this group of people.

Interventions

BEHAVIORALMindfulness for health

A course of mindfulness using the mindfulness for health programme.

Sponsors

University Hospitals of Morecambe Bay NHS Trust
CollaboratorOTHER
Rosemere Cancer Foundation, UK
CollaboratorUNKNOWN
Lancaster University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Deemed by the oncologist to have incurable cancer * Patient of the University Hospitals of Morecambe Bay NHS Foundation Trust * Treated by an oncologist * Believe they are able to commit to attending most of the mindfulness course sessions * Oncologist assesses they are well enough to participate in the intervention

Exclusion criteria

* Having any other condition or difficulty which the medical team thinks would compromise their participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Acceptability and usefulness of intervention for participantsWithin 4 weeks of the end of the interventionThis will be a qualitative outcome, collected via semi-structured interview

Secondary

MeasureTime frameDescription
Change in depression anxiety and stressCollected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the interventionUsing the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.
Change in depression anxiety and stress-3 monthsCollected before the intervention (up to 4 weeks before the intervention) and 3 months after the end of the interventionUsing the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.
Change in mindfulnessCollected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the interventionUsing the Five Factor Mindfulness Questionnaire we will measure pre-post change scores.
Acceptability and usefulness of intervention for participants- 3 months3 months following completion of the interventionThis will be a qualitative outcome, collected via semi-structured interview
Change in quality of lifeCollected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the interventionUsing the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores
Change in quality of life - 3 monthsCollected before the intervention (up to 4 weeks before the intervention) and 3 months following the interventionUsing the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores
Change in mindfulness- 3 monthsCollected before the intervention (up to 4 weeks before the intervention) and 3 months following the interventionUsing the Five Factor Mindfulness Questionnaire we will measure pre-post change scores

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026